n-acetyl-n-formyl-5-methoxykynurenamine has been researched along with sphingosine in 1 studies
Studies (n-acetyl-n-formyl-5-methoxykynurenamine) | Trials (n-acetyl-n-formyl-5-methoxykynurenamine) | Recent Studies (post-2010) (n-acetyl-n-formyl-5-methoxykynurenamine) | Studies (sphingosine) | Trials (sphingosine) | Recent Studies (post-2010) (sphingosine) |
---|---|---|---|---|---|
55 | 0 | 13 | 8,325 | 117 | 3,459 |
Protein | Taxonomy | n-acetyl-n-formyl-5-methoxykynurenamine (IC50) | sphingosine (IC50) |
---|---|---|---|
ubiquitin-conjugating enzyme E2 N | Homo sapiens (human) | 6.3125 | |
cAMP-dependent protein kinase catalytic subunit alpha | Rattus norvegicus (Norway rat) | 0.098 | |
Sphingosine kinase 2 | Homo sapiens (human) | 1.56 | |
Sphingosine kinase 1 | Homo sapiens (human) | 3.86 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dong, X; Meng, P; Qin, W; Tan, G; Wang, H; Wu, H; Yuan, J | 1 |
1 other study(ies) available for n-acetyl-n-formyl-5-methoxykynurenamine and sphingosine
Article | Year |
---|---|
Three serum metabolite signatures for diagnosing low-grade and high-grade bladder cancer.
Topics: Biomarkers, Tumor; Case-Control Studies; Demography; Female; Humans; Inosine; Kynuramine; Male; Metabolic Networks and Pathways; Metabolomics; Multivariate Analysis; Neoplasm Grading; Principal Component Analysis; Reproducibility of Results; ROC Curve; Sphingosine; Urinary Bladder Neoplasms | 2017 |